Results 281 to 290 of about 13,289,433 (300)

An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes

Drug Development and Industrial Pharmacy, 2018
Ashish Wadhwani, Hanumant Singh Rathore, Pavan Kumar Chintamaneni   +2 more
exaly  

Design and synthesis of DPP-4 inhibitor for the treatment of type 2 diabetes

Chinese Chemical Letters, 2010
exaly  

Management of a Prediabetes Case With the DPP-4 Inhibitor Sitagliptin

Annals of Pharmacotherapy, 2014
Jeremy Johnson, Katherine S O'Neal
exaly  

Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor

Bioorganic and Medicinal Chemistry, 2011
Mitsuhiro Makino, Motohiro Takeda
exaly  

Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials

Current Medical Research and Opinion, 2008
Pablo Aschner, Avraham Karasik
exaly  

Solid and solution phase syntheses of the 2-cyanopyrrolidide DPP-IV inhibitor NVP-DPP728

Tetrahedron, 2002
Willand Nicolas, Jürgen Joossens
exaly  

Discovery of Galangin as a Potential DPP-4 Inhibitor That Improves Insulin-Stimulated Skeletal Muscle Glucose Uptake: A Combinational Therapy for Diabetes

International Journal of Molecular Sciences, 2019
Poonam Kalhotra, Guillermo Osorio-Revilla, Veera Chandra Sekhar Reddy Chittepu   +2 more
exaly  

MEDICAL USE OF A DPP-4 INHIBITOR

2015
KLEIN THOMAS, ADVANI ANDREW, CONNELLY KIM ALEXANDER, GILBERT RICHARD ERNEST   +3 more
openaire   +3 more sources

DPP-4 Inhibitors: Combination Therapy

2013
Navjot Singh, Jubbin Jacob
openaire   +1 more source

Trough DPP-4 Inhibition Differs between the Approved DPP-4 Inhibitors

MD Conference Express, 2013
openaire   +1 more source